Where The Buying Ran Strongest: 54 Small Cap Stocks At 52-Week Highs
A list of strong stocks shows a sharp divergence from the flat market, raising questions about the quality of the rally.
On a day the S&P 500 is effectively flat, with a one-month return of +0.2%, a focused list of 54 Small Cap stocks is trading at 52-week highs. The largest company on the list is Corcept Therapeutics (CORT), with a market value of about $10.0 billion, after gaining 19.7% over the last month.
This raises a critical question for any disciplined investor: what kind of business performance is supporting these new highs? The names below show significant price strength, but the quality of that strength varies widely.
The Ten Largest At New Highs
- 15 S&P 500 Stocks Just Made New 52-Week Highs
- 7 S&P 500 Stocks Just Touched 52-Week Lows
- The 52-Week-Low List: 19 Names On Tuesday
- S&P 500 Movers | Winners: SNDK, WDC, MU | Losers: DHR, MSCI, TYL
- Market Movers | Winners: CPHI, UTZ, VIVK | Losers: BURU, LSTA, QMLS
- 14 Mid Cap Stocks Hit 52-Week Highs On Tuesday
The table below shows the 10 largest of the 54 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| CORT | $10.0 Bil | 4.5% | 5.7% | 19.7% | 35.0% |
| CTRE | $9.7 Bil | 2.2% | 7.2% | 18.2% | 48.8% |
| HXL | $8.2 Bil | 2.8% | 6.7% | 11.3% | 81.3% |
| SYRE | $8.1 Bil | 5.5% | 3.8% | 16.3% | 530.4% |
| SGHC | $7.9 Bil | 0.1% | 5.3% | 17.5% | 39.5% |
| PBF | $7.7 Bil | 3.4% | 8.5% | 77.1% | 180.4% |
| HR | $7.5 Bil | 1.0% | 2.8% | 8.5% | 39.9% |
| MSM | $7.1 Bil | 1.8% | 1.9% | 7.5% | 50.0% |
| TMHC | $7.0 Bil | 0.1% | 0.8% | 1.3% | 15.7% |
| KRG | $6.1 Bil | 0.5% | 4.0% | 8.0% | 40.0% |
Which new high is backed by the strongest growth?
The two largest names on the list tell different stories. Corcept Therapeutics (CORT) trades at 211.0 times trailing earnings. Its revenue grew 12.2% over the last twelve months, but its operating margin is -1.1%.
In contrast, the second-largest company, CareTrust REIT (CTRE), trades at 28.9 times trailing earnings. Its revenue grew 68.8% over the last twelve months, supported by an operating margin of 57.8%.
A 52-week high is a starting point for research, not a conclusion.
A list of stocks at their strongest price of the last year is a useful screen for what the market is rewarding. Strength can persist, and these are names with clear buyer interest.
But a price is not a verdict on a business. The disciplined move is to treat this list as a prompt for due diligence. The essential work is to check whether the underlying business fundamentals can earn a valuation that is, by definition, at a peak.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks, which is the momentum that tends to have staying power.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.